MKP-1 antagonizes C/EBPβ activity and lowers the apoptotic threshold after ischemic injury

A Rininger1, C Dejesus, A Totten

  • 1Department of Pediatrics, University of Rochester Medical Center, NY, USA.

Insights

MAPK phosphatase-1 (MKP-1) promotes cell death in the central nervous system by inhibiting the neuroprotective factor C/EBPβ. Targeting this MKP-1 and C/EBPβ interaction may offer therapeutic strategies for ischemic disorders.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • MAPK phosphatase-1 (MKP-1) regulates MAP kinase signaling and is present in the central nervous system (CNS), but its role in ischemic stress is not fully understood.
  • MKP-1 influences metabolic, inflammatory, and survival pathways, and its induction post-ischemia suggests a critical function in neuronal response.

Purpose of the Study:

  • To investigate the function of MKP-1 in the CNS, particularly its role in neuronal cell death and its interaction with neuroprotective factors.
  • To elucidate the molecular mechanisms by which MKP-1 affects cell survival and death pathways.

Main Methods:

  • In vitro studies assessing MKP-1's effects on cell death factors (BCL2,')} protein 3, caspases 3 and 12) and CCAAT/enhancer-binding protein beta (C/EBPβ).
  • Analysis of C/EBPβ expression and phosphorylation in response to MKP-1.
  • Rescue experiments using enforced C/EBPβ expression.
  • Studies in MKP-1 knockout mice to evaluate MKP-1's role in basal C/EBPβ localization and its response to global forebrain ischemia.

Main Results:

  • MKP-1 induced apoptotic cell death in vitro by activating cell death factors and caspases.
  • MKP-1 inhibited C/EBPβ, reducing its expression and phosphorylation at a key site.
  • Enforced C/EBPβ expression protected cells from MKP-1-induced toxicity.
  • MKP-1 activity was necessary for excluding C/EBPβ from the nucleus and antagonized C/EBPβ expression after ischemia, especially in the hippocampus.
  • MKP-1 lowers the apoptotic threshold by inhibiting C/EBPβ and increasing BH3 protein and caspase activity.

Conclusions:

  • MKP-1 promotes neuronal cell death by inhibiting the neuroprotective transcription factor C/EBPβ.
  • The MKP-1-C/EBPβ axis is a critical regulator of apoptosis in the CNS following ischemic injury.
  • Targeting the MKP-1-C/EBPβ interaction may hold therapeutic potential for ischemic disorders, but inhibiting MKP-1's phosphatase activity alone might be insufficient.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...